Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 34, 2022 - Issue 4
600
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Cannabis use, pain interference, and prescription opioid receipt among persons with HIV: a target trial emulation study

ORCID Icon, , , , , ORCID Icon & show all
Pages 469-477 | Received 02 Nov 2020, Accepted 09 Jun 2021, Published online: 28 Jun 2021

References

  • Anderson, K. O., Green, C. R., & Payne, R. (2009). Racial and ethnic disparities in pain: Causes and consequences of unequal care. The Journal of Pain, 10(12), 1187–1204. https://doi.org/10.1016/j.jpain.2009.10.002
  • Bair, M. J., Wu, J., Damush, T. M., Sutherland, J. M., & Kroenke, K. (2008). Association of depression and anxiety alone and in combination with chronic musculoskeletal pain in primary care patients. Psychosomatic Medicine, 70(8), 890. https://doi.org/10.1097/PSY.0b013e318185c510
  • Becker, W. C., Gordon, K., Edelman, E. J., Kerns, R. D., Crystal, S., Dziura, J. D., Fiellin, L. E., Gordon, A. J., Goulet, J. L., Justice, A. C., & Fiellin, D. A. (2016). Trends in any and high-dose opioid analgesic receipt among aging patients with and without HIV. AIDS and Behavior, 20(3), 679–686. https://doi.org/10.1007/s10461-015-1197-5
  • Bohnert, A. S., Valenstein, M., Bair, M. J., Ganoczy, D., McCarthy, J. F., Ilgen, M. A., & Blow, F. C. (2011). Association between opioid prescribing patterns and opioid overdose-related deaths. Jama, 305(13), 1315–1321. https://doi.org/10.1001/jama.2011.370
  • Campbell, G., Hall, W. D., Peacock, A., Lintzeris, N., Bruno, R., Larance, B., Nielsen, S., Cohen, M., Chan, G., Mattick, R. P., & Blyth, F. (2018). Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: Findings from a 4-year prospective cohort study. The Lancet Public Health, 3(7), e341–e350. https://doi.org/10.1016/S2468-2667(18)30110-5
  • Caniglia, E. C., Rebecca, Z. A., Jacobson, D. L., Diseko, M., Mayondi, G., Lockman, S., Jennifer, C. H., Mmalane, M., Makhema, J., Hernán, M. A., & Shapiro, R. L. (2018). Emulating a target trial of antiretroviral therapy regimens started before conception and risk of adverse birth outcomes. AIDS (London, England), 32(1), 113. https://doi.org/10.1097/QAD.0000000000001673
  • Caniglia, E. C., Stevens, E. R., Khan, M., Young, K. E., Ban, K., Marshall, B. D., Chichetto, N. E., Gaither, J. R., Crystal, S., Edelman, E. J., & Fiellin, D. A. (2020). Does reducing drinking in patients with unhealthy alcohol use improve pain interference, use of other substances, and psychiatric symptoms? Alcoholism: Clinical and Experimental Research 44(11). https://doi.org/10.1111/acer.14455. pp 2257-2265
  • Chayama, K. L., Valleriani, J., Ng, C., Haines-Saah, R., Capler, R., Milloy, M. J., Small, W., & McNeil, R. (2021). The role of cannabis in pain management among people living with HIV who use drugs: A qualitative study. Drug and Alcohol Review, https://doi.org/10.1111/dar.13294
  • Chou, R., Turner, J. A., Devine, E. B., Hansen, R. N., Sullivan, S. D., Blazina, I., Dana, T., Bougatsos, C., & Deyo, R. A. (2015). The effectiveness and risks of long-term opioid therapy for chronic pain: A systematic review for a National Institutes of Health pathways to prevention workshop. Annals of Internal Medicine, 162(4), 276–286. https://doi.org/10.7326/M14-2559
  • Cooke, A. C., Knight, K. R., & Miaskowski, C. (2019). Patients’ and clinicians’ perspectives of co-use of cannabis and opioids for chronic non-cancer pain management in primary care. International Journal of Drug Policy, 63, 23–28. https://doi.org/10.1016/j.drugpo.2018.09.002
  • Dowell, D., Haegerich, T. M., & Chou, R. (2016). CDC guideline for prescribing opioids for chronic pain—United States, 2016. Jama, 315(15), 1624–1645. https://doi.org/10.1001/jama.2016.1464
  • Dworkin, R. H., Turk, D. C., Farrar, J. T., Haythornthwaite, J. A., Jensen, M. P., Katz, N. P., Kerns, R. D., Stucki, G., Allen, R. R., Bellamy, N., & Carr, D. B. (2005). Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain, 113(1), 9–19. https://doi.org/10.1016/j.pain.2004.09.012
  • Edelman, E. J., Gordon, K., Becker, W. C., Goulet, J. L., Skanderson, M., Gaither, J. R., Braden, J. B., Gordon, A. J., Kerns, R. D., Justice, A. C., & Fiellin, D. A. (2013). Receipt of opioid analgesics by HIV-infected and uninfected patients. Journal of General Internal Medicine, 28(1), 82–90. https://doi.org/10.1007/s11606-012-2189-z
  • Edelman, E. J., Gordon, K. S., Crothers, K., Akgün, K., Bryant, K. J., Becker, W. C., Gaither, J. R., Gibert, C. L., Gordon, A. J., Marshall, B. D., & Rodriguez-Barradas, M. C. (2019). Association of prescribed opioids With increased risk of community-acquired pneumonia among patients with and without HIV. JAMA Internal Medicine 179(3). https://doi.org/10.1001/jamainternmed.2018.6101
  • Frank, J. W., Lovejoy, T. I., Becker, W. C., Morasco, B. J., Koenig, C. J., Hoffecker, L., Dischinger, H. R., Dobscha, S. K., & Krebs, E. E. (2017). Patient outcomes in dose reduction or discontinuation of long-term opioid therapy: A systematic review. Annals of Internal Medicine, 167(3), 181–191. https://doi.org/10.7326/M17-0598
  • Gaither, J. R., Gordon, K., Crystal, S., Edelman, E. J., Kerns, R. D., Justice, A. C., Fiellin, D. A., & Becker, W. C. (2018). Racial disparities in discontinuation of long-term opioid therapy following illicit drug use among black and white patients. Drug and Alcohol Dependence, 192, 371–376. https://doi.org/10.1016/j.drugalcdep.2018.05.033
  • Ghosh, S., Chandran, A., & Jansen, J. P. (2012). Epidemiology of HIV-related neuropathy: A systematic literature review. AIDS Research and Human Retroviruses, 28(1), 36–48. https://doi.org/10.1089/aid.2011.0116
  • Gordon, K. S., Manhapra, A., Crystal, S., Dziura, J., Edelman, E. J., Skanderson, M., Kerns, R. D., Justice, A. C., Tate, J., & Becker, W. C. (2020). All-cause mortality among males living with and without HIV initiating long-term opioid therapy, and its association with opioid dose, opioid interruption and other factors. Drug and Alcohol Dependence, 216, 108291. https://doi.org/10.1016/j.drugalcdep.2020.108291
  • Green, C. R., Anderson, K. O., Baker, T. A., Campbell, L. C., Decker, S., Fillingim, R. B., Kaloukalani, D. A., Lasch, K. E., Myers, C., Tait, R. C., & Todd, K. H. (2003). The unequal burden of pain: Confronting racial and ethnic disparities in pain. Pain Medicine, 4(3), 277–294. https://doi.org/10.1046/j.1526-4637.2003.03034.x
  • Hamilton, I., & Gage, S. H. (2018). A painful lesson: Are we repeating previous mistakes in pain management? The Lancet Public Health, 3(7), e309–e310. https://doi.org/10.1016/S2468-2667(18)30117-8
  • Hernán, M. A., & Robins, J. M. (2016). Using big data to emulate a target trial when a randomized trial is not available. American Journal of Epidemiology, 183(8), 758–764. https://doi.org/10.1093/aje/kwv254
  • Justice, A. C., Dombrowski, E., Conigliaro, J., Fultz, S. L., Gibson, D., Madenwald, T., Goulet, J., Simberkoff, M., Butt, A. A., Rimland, D., & Rodriguez-Barradas, M. C. (2006). Veterans aging cohort study (VACS): overview and description. Medical Care, 44(8 Suppl 2), S13. https://doi.org/10.1097/01.mlr.0000223741.02074.66
  • Krcevski-Skvarc, N. (2018). Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European pain federation. European Journal of Pain, 22(3), 440–454. https://doi.org/10.1002/ejp.1147
  • Krebs, E. E., Gravely, A., Nugent, S., Jensen, A. C., DeRonne, B., Goldsmith, E. S., Kroenke, K., Bair, M. J., & Noorbaloochi, S. (2018). Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain: The SPACE randomized clinical trial. Jama, 319(9), 872–882. https://doi.org/10.1001/jama.2018.0899
  • Maharajan, M. K., Yong, Y. J., Yip, H. Y., Woon, S. S., Yeap, K. M., Yap, K. Y., Yip, S. C., & Yap, K. X. (2020). Medical cannabis for chronic pain: Can it make a difference in pain management? Journal of Anesthesia 34, 1–9. https://doi.org/10.1007/s00540-019-02680-y
  • Merlin, J. S., Bulls, H. W., Vucovich, L. A., Edelman, E. J., & Starrels, J. L. (2016). Pharmacologic and non-pharmacologic treatments for chronic pain in individuals with HIV: A systematic review. AIDS Care, 28(12), 1506–1515. https://doi.org/10.1080/09540121.2016.1191612
  • Merlin, J. S., Long, D., Becker, W. C., Cachay, E. R., Christopolous, K. A., Claborn, K. R., Crane, H. M., Edelman, E. J., Lovejoy, T. I., Mathews, W. C., & Morasco, B. J. (2019). Marijuana Use Is Not associated with changes in opioid prescriptions or pain severity among people living with HIV and chronic pain. Journal of Acquired Immune Deficiency Syndromes (1999), 81(2), 231–237. https://doi.org/10.1097/QAI.0000000000001998
  • Merlin, J. S., Long, D., Becker, W. C., Cachay, E. R., Christopoulos, K. A., Claborn, K., Crane, H. M., Edelman, E. J., Harding, R., Kertesz, S. G., & Liebschutz, J. M. (2018). The association of chronic pain and long-term opioid therapy with HIV treatment outcomes. Journal of Acquired Immune Deficiency Syndromes (1999), 79(1), 77. https://doi.org/10.1097/QAI.0000000000001741
  • Merlin, J. S., Selwyn, P. A., Treisman, G. J., & Giovanniello, A. G. (2016). Chronic pain and HIV. Wiley Online Library.
  • Mücke, M., Phillips, T., Radbruch, L., Petzke, F., & Häuser, W. (2018). Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews, 3(3). https://doi.org/10.1002/14651858.CD012182.pub2
  • National Conference of State Legislatures. (2020). State Medical Marijuana Laws. https://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx
  • Nielsen, S., Sabioni, P., Trigo, J. M., Ware, M. A., Betz-Stablein, B. D., Murnion, B., Lintzeris, N., Khor, K. E., Farrell, M., Smith, A., & Le Foll, B. (2017). Opioid-sparing effect of cannabinoids: A systematic review and meta-analysis. Neuropsychopharmacology, 42(9), 1752–1765. https://doi.org/10.1038/npp.2017.51
  • Nugent, S. M., Morasco, B. J., O'Neil, M. E., Freeman, M., Low, A., Kondo, K., Elven, C., Zakher, B., Motu'apuaka, M., Paynter, R., & Kansagara, D. (2017). The effects of cannabis among adults with chronic pain and an overview of general harms: A systematic review. Annals of Internal Medicine, 167(5), 319–331. https://doi.org/10.7326/M17-0155
  • Savage, S. R., Romero-Sandoval, A., Schatman, M., Wallace, M., Fanciullo, G., McCarberg, B., & Ware, M. (2016). Cannabis in pain treatment: Clinical and research considerations. The Journal of Pain, 17(6), 654–668. https://doi.org/10.1016/j.jpain.2016.02.007
  • Sohler, N. L., Starrels, J. L., Khalid, L., Bachhuber, M. A., Arnsten, J. H., Nahvi, S., Jost, J., & Cunningham, C. O. (2018). Cannabis use is associated with lower odds of prescription opioid analgesic use among HIV-infected individuals with chronic pain. Substance Use & Misuse, 53(10), 1602–1607. https://doi.org/10.1080/10826084.2017.1416408
  • Solomon, D. H., Rassen, J. A., Glynn, R. J., Garneau, K., Levin, R., Lee, J., & Schneeweiss, S. (2010). The comparative safety of opioids for nonmalignant pain in older adults. Archives of Internal Medicine, 170(22), 1979–1986. https://doi.org/10.1001/archinternmed.2010.450
  • Tate, J. P., Sterne, J. A. C., & Justice, A. C. (2019). Albumin, white blood cell count, and body mass index improve discrimination of mortality in HIV-positive individuals. AIDS, 33(5), 903–912. https://doi.org/10.1097/qad.0000000000002140
  • Uebelacker, L. A., Weisberg, R. B., Herman, D. S., Bailey, G. L., Pinkston-Camp, M. M., & Stein, M. D. (2015). Chronic pain in HIV-infected patients: Relationship to depression, substance use, and mental health and pain treatment. Pain Medicine, 16(10), 1870–1881. https://doi.org/10.1111/pme.12799
  • VA/DoD. (2017). Clinical Practice Guideline for Opioid Therapy for Chronic Pain(version 3.0).
  • Weisberg, D. F., Gordon, K. S., Barry, D. T., Becker, W. C., Crystal, S., Edelman, E. J., Gaither, J., Gordon, A. J., Goulet, J., Kerns, R. D., & Moore, B. A. (2015). Long-term prescription opioids and/or benzodiazepines and mortality among HIV-infected and uninfected patients. Journal of Acquired Immune Deficiency Syndromes (1999), 69(2), 223. https://doi.org/10.1097/QAI.0000000000000591

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.